09:52 AM EST - Helix BioPharma Corp. : announced that it will file a Form 15F with the United States Securities and Exchange Commission with the intention of terminating registration of its common shares under Section 12(g) of the United States Securities Exchange Act of 1934, as amended and terminating its reporting obligations for all of its registered securities under Section 15(d) of the Exchange Act. Helix BioPharma Corp.
shares T.HBP are trading unchanged at $1.35.
